Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Jan;30(1):17–24. doi: 10.1128/jcm.30.1.17-24.1992

Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections.

D S Lin 1, D D Bowman 1, R H Jacobson 1
PMCID: PMC264990  PMID: 1346403

Abstract

To examine the immunological changes in cats concurrently infected with feline immunodeficiency virus (FIV) and Toxoplasma gondii, kittens (four per group) were inoculated with FIV, T. gondii, both agents, or no pathogens. Blood mononuclear cells and plasma were collected weekly for lymphocyte assays and serology. At week 14, spleen and lymph node cells were used for lymphocyte assays; brains and mesenteric lymph nodes were used for isolation of T. gondii. More T. gondii organisms were present in tissues of the dually infected cats than in tissues of cats with toxoplasmosis alone. Two dually infected cats and one cat infected with T. gondii developed chorioretinitis. Spleen, lymph node, and blood mononuclear cells from dually infected cats had the greatest reduction in mitogenic responses. By week 3, cats infected with FIV underwent a decrease in the number of CD4 cells that was not changed by concurrent T. gondii infection; the number of CD8 cells increased only in cats infected with T. gondii alone. For cats infected with T. gondii, the responses of lymphocytes to T. gondii antigen were not affected by FIV infection; the responses to FIV antigen were negligible in all groups. Overall, this study indicates that FIV infection favors T. gondii proliferation. Also, the establishment of toxoplasmosis may enhance FIV-induced immunodeficiency and is likely to cause a more rapid disease progression than that from infection with FIV alone.

Full text

PDF
17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackley C. D., Hoover E. A., Cooper M. D. Identification of a CD4 homologue in the cat. Tissue Antigens. 1990 Feb;35(2):92–98. doi: 10.1111/j.1399-0039.1990.tb01762.x. [DOI] [PubMed] [Google Scholar]
  2. Barlough J. E., Jacobson R. H., Downing D. R., Marcella K. L., Lynch T. J., Scott F. W. Evaluation of a computer-assisted, kinetics-based enzyme-linked immunosorbent assay for detection of coronavirus antibodies in cats. J Clin Microbiol. 1983 Feb;17(2):202–217. doi: 10.1128/jcm.17.2.202-217.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biggar R. J., Gigase P. L., Melbye M., Kestens L., Sarin P. S., Bodner A. J., Demedts P., Stevens W. J., Paluku L., Delacollette C. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet. 1985 Sep 7;2(8454):520–523. doi: 10.1016/s0140-6736(85)90461-1. [DOI] [PubMed] [Google Scholar]
  4. Chang H. R., Grau G. E., Pechère J. C. Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology. 1990 Jan;69(1):33–37. [PMC free article] [PubMed] [Google Scholar]
  5. Cockerell G. L., Hoover E. A., Krakowka S., Olsen R. G., Yohn D. S. Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat. J Natl Cancer Inst. 1976 Nov;57(5):1095–1099. doi: 10.1093/jnci/57.5.1095. [DOI] [PubMed] [Google Scholar]
  6. Dubey J. P., Frenkel J. K. Immunity to feline toxoplasmosis: modification by administration of corticosteroids. Vet Pathol. 1974;11(4):350–379. doi: 10.1177/030098587401100407. [DOI] [PubMed] [Google Scholar]
  7. Duquesne V., Auriault C., Darcy F., Decavel J. P., Capron A. Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells. Infect Immun. 1990 Jul;58(7):2120–2126. doi: 10.1128/iai.58.7.2120-2126.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Holliman R. E. Toxoplasmosis and the acquired immune deficiency syndrome. J Infect. 1988 Mar;16(2):121–128. doi: 10.1016/s0163-4453(88)93847-9. [DOI] [PubMed] [Google Scholar]
  9. Khalife J., Grzych J. M., Pierce R., Ameisen J. C., Schacht A. M., Gras-Masse H., Tartar A., Lecocq J. P., Capron A. Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni. J Exp Med. 1990 Sep 1;172(3):1001–1004. doi: 10.1084/jem.172.3.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Khan I. A., Smith K. A., Kasper L. H. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol. 1988 Nov 15;141(10):3600–3605. [PubMed] [Google Scholar]
  11. Klotz F. W., Cooper M. D. A feline thymocyte antigen defined by a monoclonal antibody (FT2) identifies a subpopulation of non-helper cells capable of specific cytotoxicity. J Immunol. 1986 Apr 1;136(7):2510–2514. [PubMed] [Google Scholar]
  12. Krowka J. F., Stites D. P., Jain S., Steimer K. S., George-Nascimento C., Gyenes A., Barr P. J., Hollander H., Moss A. R., Homsy J. M. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J Clin Invest. 1989 Apr;83(4):1198–1203. doi: 10.1172/JCI114001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lane H. C., Depper J. M., Greene W. C., Whalen G., Waldmann T. A., Fauci A. S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985 Jul 11;313(2):79–84. doi: 10.1056/NEJM198507113130204. [DOI] [PubMed] [Google Scholar]
  14. Lappin M. R., Greene C. E., Winston S., Toll S. L., Epstein M. E. Clinical feline toxoplasmosis. Serologic diagnosis and therapeutic management of 15 cases. J Vet Intern Med. 1989 Jul-Sep;3(3):139–143. doi: 10.1111/j.1939-1676.1989.tb03089.x. [DOI] [PubMed] [Google Scholar]
  15. Lin D. S., Bowman D. D. Cellular responses of cats with primary toxoplasmosis. J Parasitol. 1991 Apr;77(2):272–279. [PubMed] [Google Scholar]
  16. Lin D. S., Bowman D. D., Jacobson R. H., Barr M. C., Fevereiro M., Williams J. R., Noronha F. M., Scott F. W., Avery R. J. Suppression of lymphocyte blastogenesis to mitogens in cats experimentally infected with feline immunodeficiency virus. Vet Immunol Immunopathol. 1990 Oct;26(2):183–189. doi: 10.1016/0165-2427(90)90066-2. [DOI] [PubMed] [Google Scholar]
  17. Lin D. S., Lai S. S., Bowman D. D., Jacobson R. H., Barr M. C., Giovengo S. L. Feline immunodeficiency virus, feline leukaemia virus, Toxoplasma gondii, and intestinal parasitic infections in Taiwanese cats. Br Vet J. 1990 Sep-Oct;146(5):468–475. doi: 10.1016/0007-1935(90)90037-4. [DOI] [PubMed] [Google Scholar]
  18. Lo S. C., Tsai S., Benish J. R., Shih J. W., Wear D. J., Wong D. M. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science. 1991 Mar 1;251(4997):1074–1076. doi: 10.1126/science.1705362. [DOI] [PubMed] [Google Scholar]
  19. Marmor M., Friedman-Kien A. E., Zolla-Pazner S., Stahl R. E., Rubinstein P., Laubenstein L., William D. C., Klein R. J., Spigland I. Kaposi's sarcoma in homosexual men. A seroepidemiologic case-control study. Ann Intern Med. 1984 Jun;100(6):809–815. doi: 10.7326/0003-4819-100-6-809. [DOI] [PubMed] [Google Scholar]
  20. Miedema F., Tersmette M., van Lier R. A. AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunol Today. 1990 Aug;11(8):293–297. doi: 10.1016/0167-5699(90)90116-q. [DOI] [PubMed] [Google Scholar]
  21. Olmsted R. A., Barnes A. K., Yamamoto J. K., Hirsch V. M., Purcell R. H., Johnson P. R. Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2448–2452. doi: 10.1073/pnas.86.7.2448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Omata Y., Oikawa H., Kanda M., Mikazuki K., Nakabayashi T., Suzuki N. Experimental feline toxoplasmosis: humoral immune responses of cats inoculated orally with Toxoplasma gondii cysts and oocysts. Nihon Juigaku Zasshi. 1990 Aug;52(4):865–867. doi: 10.1292/jvms1939.52.865. [DOI] [PubMed] [Google Scholar]
  23. Pedersen N. C., Ho E. W., Brown M. L., Yamamoto J. K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 1987 Feb 13;235(4790):790–793. doi: 10.1126/science.3643650. [DOI] [PubMed] [Google Scholar]
  24. Quinn T. C., Piot P., McCormick J. B., Feinsod F. M., Taelman H., Kapita B., Stevens W., Fauci A. S. Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA. 1987 May 15;257(19):2617–2621. [PubMed] [Google Scholar]
  25. Radvany R. M., Schubert M. S., Kiamar M., Jarzabek V., Koehler-Carone K., Kuban D., Hecht F. Lymphocyte subpopulation profiles and mitogen kinetics in immunological deficiency testing. J Clin Immunol. 1987 Jul;7(4):312–318. doi: 10.1007/BF00915553. [DOI] [PubMed] [Google Scholar]
  26. Rogers M. F., Morens D. M., Stewart J. A., Kaminski R. M., Spira T. J., Feorino P. M., Larsen S. A., Francis D. P., Wilson M., Kaufman L. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results. Ann Intern Med. 1983 Aug;99(2):151–158. doi: 10.7326/0003-4819-99-2-151. [DOI] [PubMed] [Google Scholar]
  27. Rosenberg Z. F., Fauci A. S. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today. 1990 May;11(5):176–180. doi: 10.1016/0167-5699(90)90070-p. [DOI] [PubMed] [Google Scholar]
  28. Suzuki Y., Remington J. S. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol. 1988 Jun 1;140(11):3943–3946. [PubMed] [Google Scholar]
  29. Suzuki Y., Remington J. S. The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J Immunol. 1990 Mar 1;144(5):1954–1956. [PubMed] [Google Scholar]
  30. Wahren B., Morfeldt-Månsson L., Biberfeld G., Moberg L., Ljungman P., Nordlund S., Bredberg-Rådén U., Werner A., Löwer J., Kurth R. Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection. N Engl J Med. 1986 Aug 7;315(6):393–394. [PubMed] [Google Scholar]
  31. Wahren B., Morfeldt-Månsson L., Biberfeld G., Moberg L., Sönnerborg A., Ljungman P., Werner A., Kurth R., Gallo R., Bolognesi D. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol. 1987 Jun;61(6):2017–2023. doi: 10.1128/jvi.61.6.2017-2023.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Weiss A., Margo C. E., Ledford D. K., Lockey R. F., Brinser J. H. Toxoplasmic retinochoroiditis as an initial manifestation of the acquired immune deficiency syndrome. Am J Ophthalmol. 1986 Feb 15;101(2):248–249. doi: 10.1016/0002-9394(86)90605-7. [DOI] [PubMed] [Google Scholar]
  33. Witt C. J., Moench T. R., Gittelsohn A. M., Bishop B. D., Childs J. E. Epidemiologic observations on feline immunodeficiency virus and Toxoplasma gondii coinfection in cats in Baltimore, Md. J Am Vet Med Assoc. 1989 Jan 15;194(2):229–233. [PubMed] [Google Scholar]
  34. Yamamoto J. K., Sparger E., Ho E. W., Andersen P. R., O'Connor T. P., Mandell C. P., Lowenstine L., Munn R., Pedersen N. C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res. 1988 Aug;49(8):1246–1258. [PubMed] [Google Scholar]
  35. Zagury D., Bernard J., Leonard R., Cheynier R., Feldman M., Sarin P. S., Gallo R. C. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 1986 Feb 21;231(4740):850–853. doi: 10.1126/science.2418502. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES